INTRODUCTION
Over the last 10 years, 16S rRNA gene sequence analysis of non-tuberculous mycobacteria (NTM) has led to the description of 45 novel species and has contributed to the description of novel clinical isolates. Infections caused by rapidly growing mycobacteria (RGM) have received greater clinical attention in recent years because of their increasing incidence in AIDS patients (Smith et al., 2001; Wallace et al., 1993 Wallace et al., , 1997 as well as in non-immunocompromised patients (Brown-Elliott & Wallace, 2002) . Many RGM are ubiquitous in the environment and water has been shown to be an important source of these opportunistic mycobacteria (Covert et al., 1999; Dailloux et al., 1999; Wallace et al., 1998) . This fact is illustrated by reports of cases such as Mycobacterium fortuitum furunculosis following footbaths (Winthrop et al., 2002) , a disseminated infection in a leukaemia patient (Kauppinen et al., 1999) and hypersensitivity pneumonitis in automobile workers exposed to metalworking fluids Wilson et al., 2001) . Likewise, contamination of hospital equipment and medication, traced to the ubiquitous presence of these organisms in tap water and their resistance to commonly used disinfectants (Tiwari et al., 2003; Wallace et al., 1998) , was responsible for pseudo-outbreaks of infections associated with surgical implants, health care-associated septicaemia and lung disease following bronchoscopy (Anaissie et al., 2002; Ashford et al., 1997; Ferguson et al., 2004; Lai et al., 1998; Wallace et al., 1998) . The most common types of infection are skin and soft tissue infections, infections characterized by slowly progressive granulomatous inflammation, lymphadenitis and skeletal, catheter-related, disseminated and pulmonary infections (Brown-Elliott & Wallace, 2002; Schinsky et al., 2004) .
Increasing recovery of RGM from environmental and clinical sources has prompted the development of laboratory methods to determine their taxonomic affiliation and identify them precisely. Accurate identification of RGM species is a key step towards the description of the emerging opportunistic infections that they cause. Conventional laboratory methods alone are unable to discriminate between RGM because of their overlapping phenotypic patterns (Conville & Witebsky, 1998; Springer et al., 1996) . Cell-wall fatty acid and mycolic acid composition analysis contributed to the identification of novel mycobacterial species (Butler & Kilburn, 1990; Munoz et al., 1997) , but the discriminatory power of the analyses was limited by profile similarity among emerging RGM (Wilson et al., 2001) . 16S rRNA gene sequencing has been used as the first-line method for the identification of unusual mycobacterial isolates (Pauls et al., 2003; Tortoli et al., 2001 ) and for further discrimination of emerging NTM (Böddinghaus et al., 1990; Rogall et al., 1990) . It has contributed greatly to the delineation of novel species of the genus Mycobacterium and to the description of new clinical forms due to known NTM. However, 16S rRNA gene sequence-based description of novel mycobacterial taxa is still a matter of debate.
Ambiguous results can be obtained due to the possible presence of two copies of the 16S rRNA gene with different sequences in the same organism (Adékambi & Drancourt, 2004; Ninet et al., 1996; Reischl et al., 1998; Turenne et al., 2001) . Closely related RGM species, such as Mycobacterium houstonense and Mycobacterium senegalense, cannot be discriminated by this molecular tool (Adékambi et al., 2003; Adékambi & Drancourt, 2004) .
Partial sequencing of PCR-amplified rpoB, the gene encoding the b-subunit of bacterial RNA polymerase, has been developed as a suitable tool for the accurate identification of RGM (Adékambi et al., 2003) and its usefulness for determining the taxonomy of this group of micro-organisms has been demonstrated (Adékambi & Drancourt, 2004) . In this study, this new tool was applied to a collection of clinical RGM isolates and 9/59 isolates from 52 patients were found to exhibit three original rpoB sequences, indicative of novel RGM species. A polyphasic investigation, including biochemical tests, antimicrobial susceptibility analyses, DNA G+C content determination, cell-wall fatty acid composition analyses and sequence-based analyses, confirmed that these isolates were indeed prototype strains for emerging RGM of clinical interest. The names Mycobacterium bolletii sp. nov., Mycobacterium phocaicum sp. nov. and Mycobacterium aubagnense sp. nov. are proposed for these three novel RGM.
METHODS
Mycobacterial strains, genetic and phylogenetic analyses.
The nine isolates under study and their clinical sources are listed in Table 1 . In addition, we determined sequences for two RGM species: 'Mycobacterium massiliense' CIP 108297 and Mycobacterium alvei CIP 103464 T . These newly determined sequences were added to those of 20 species studied previously (Adékambi et al., 2003) . DNA was extracted from colonies grown on 5 % sheep blood agar using the Fast-prep device and the FastDNA kit according to the manufacturer's recommendations (BIO 101). Five molecular targets including the 16S rRNA (Weisburg et al., 1991) , hsp65 (Telenti et al., 1993) , (Thompson et al., 1997) . A phylogenetic tree was obtained from DNA sequences by using the neighbour-joining method with Kimura's two-parameter (K2P) distance correction model with 1000 bootstrap replications in the MEGA version 2.1 software package (Kumar et al., 2001) . The tree was rooted using Mycobacterium tuberculosis and Mycobacterium leprae.
The sequences determined in this study have been deposited in GenBank/EMBL/DDBJ (Table 1 and Fig. 1 ).
DNA G+C content determination and cellular fatty acid analysis. After culture on 5 % sheep blood agar for 3 days, DNA extraction, purification, degradation and determination of the DNA G+C content by HPLC were performed as described by Mesbah et al. (1989) except that a Waters 625 LC system with a Waters 486 Tenable Absorbance Detector and a Waters 746 Data Module (Millipore) were used. Three determinations were performed. Total fatty acid methyl esters were extracted and prepared by following the instructions for the Microbial Identification System (Microbial ID) and were analysed by GLC using a gas chromatograph (HP 6890A; Hewlett Packard). Identification of fatty acids for isolates BD T , N4 T and U8 T was performed using the Microbial Identification System with a library created using Sherlock Library Generation System version 4.0 software (Sasser, 1990) .
Phenotypic characterization of the isolates. Sputum and bronchioalveolar specimens were decontaminated as previously described (Kent & Kubica, 1985; Kubica et al., 1963) . Half of the sediment was frozen whilst the other half was inoculated into BACTEC 9000MB broth according to the manufacturer's instructions (BD Biosciences) after Ziehl-Neelsen staining. The joint fluid specimen was inoculated directly into BACTEC 9000MB broth. Mycobacteria were subcultured on Middlebrook 7H10 agar, eggbased Lowenstein-Jensen (LJ) slants (bioMérieux) and 5 % sheep blood agar (bioMérieux) and cultures were inspected twice weekly Fig. 1 . Phylogenetic tree of the partial rpoB gene sequences of the three novel mycobacterial species and 21 RGM prepared by using the neighbour-joining method and Kimura's two-parameter distance correction model. The support of each branch, as determined from 1000 bootstrap samples, is indicated by the value at each node (as a percentage). M. tuberculosis and M. leprae were used as the outgroups. Bar, 2 % difference in nucleotide sequences.
for the presence of colonies. We observed colony morphology, pigmentation and the ability of the isolate to grow at various temperatures (24, 30, 37 and 42 uC) on 5 % sheep blood agar, LJ slants, Middlebrook 7H10 agar and LJ slants in the presence of 5 % NaCl. We tested the activities of arylsulfatase and catalase, iron uptake and degradation of p-aminosalicylic acid (Kent & Kubica, 1985; Vincent et al., 2003) . Additional biochemical tests were performed by inoculation of API Coryne and API 20E strips (bioMérieux) (Adékambi et al., 2004) according to the manufacturer's instructions with an incubation time of 3 days at 30 uC under a highly humidified atmosphere.
Antibiotic susceptibility testing. Mycobacterial suspensions of the isolates were prepared by emulsifying colonies grown on 5 % sheep blood agar slants into 5 ml sterile water to achieve a density equal to a 1?0 McFarland turbidity standard by visual examination. Suspensions were mixed vigorously on a vortex mixer for 20 s and then inoculated on the entire surface of a 5 % sheep blood agar plate. The minimum inhibitory concentrations (MIC) of rifampicin, ciprofloxacin, ofloxacin, sparfloxacin, doxycycline, minocycline, erythromycin, clarithromycin, azithromycin, amikacin, penicillin, amoxycillin, imipenem, cefotaxime, ceftriaxone, metronidazole, teicoplanin and vancomycin were determined by incubation with the respective E-test (AB Biodisk) at 30 uC for 3 days. An additional disk-diffusion method on 5 % sheep blood agar for 3 days at 30 uC was used to determine the susceptibility to trimethoprim/sulfamethoxazole (1?25/23?75 mg), tobramycin (10 mg), amoxycillin/clavulanate (30 mg), pipemidic acid (30 mg), cefalotin (30 mg) and cefoxitin (30 mg). The MIC of the antimicrobial agents tested was determined according to the breakpoints recommended by the NCCLS (NCCLS 2002 (NCCLS , 2003 and those proposed by Brown-Elliott & Wallace (2002) . Every test was done three times on three separate days in order to ensure the reproducibility of results.
RESULTS

Mycobacterial strains
Of the nine isolates studied, three isolates (N4 T , N30 and U8 T ) were recovered from bronchial aspirate specimens, four isolates (BD T , U2, U6 and N9) from sputum specimens, one isolate (E2) from a stomach aspirate and one isolate (D5) from joint fluid.
Genetic and phylogenetic analyses
We showed previously that RGM isolates belong to the same species if they have <2 % partial rpoB gene sequence divergence from an established species. Isolates can be considered to belong to a novel species if they exhibit >3 % rpoB sequence divergence from established species using the partial 723 bp rpoB sequence (Adékambi et al., 2003 (Adékambi et al., , 2004 T partial rpoB gene amino-acid sequence numbering). rpoB gene sequence variation was not observed among isolates belonging to the same species. An rpoB phylogenetic tree was created that included a representative sequence for each of the nine isolates and 21 sequences from established RGM species tested in our laboratory (Fig. 1) . These analyses suggested that strain BD T was recently derived from M. abscessus and belongs to the Mycobacterium chelonae-M. abscessus group. Strain N4 T and U8 T were closely related to M. mucogenicum and belonged to the M. mucogenicum group. A bootstrap value ¢75 % in the neighbour-joining tree supported the fork separating strain BD T , strain N4 T and strain U8 T from the closely related species. Their lineages were clearly different from that of closely related species and quite distant from other recognized RGM.
Further sequence analyses of the 16S rRNA gene sequences over 1483 bp showed that isolates BD T , E2, U2 and U6 shared 100 % sequence similarity with M. abscessus ATCC 19977 T , isolates N4
T , N9 and N30 shared 100 % sequence similarity with M. mucogenicum ATCC 49650
T and isolates U8
T and D5 shared 99?1 % sequence similarity with M. mucogenicum ATCC 49650 T (14 bp difference). Further molecular characterization of the seven isolates for which the 16S rRNA sequence exhibited 100 % similarity with the corresponding type strain, but showed large differences in the rpoB gene sequence, was done by analysis of the hsp65, sodA and recA gene sequences. For the hsp65, sodA and recA genes, strain BD T shared 98?2, 97?7 and 97?9 % similarity, respectively, with M. abscessus. Strain N4
T showed 98?8 % similarity with M. mucogenicum ATCC 49650 T in the hsp65 gene sequence, 98?3 % for the sodA gene and 98?4 % for the recA gene. Thus, the isolates initially identified as M. abscessus or as M. mucogenicum ATCC 49650
T on the basis of their phenotypic pattern and 16S rRNA gene sequencing were unambiguously distinguished from closely related species by rpoB, recA, sodA and hsp65 gene sequencing. The one remaining novel strain, U8
T , shared 96?0 % similarity with M. mucogenicum ATCC 49650 T in the hsp65 gene sequence, 96?6 % in the sodA gene and 94?8 % in the recA gene. Complete rpoB gene sequence analyses of the three novel species revealed similar relationships to the partial rpoB sequence analysis described previously (Adékambi et al., 2003) . Molecular analysis, including sequence analyses of the 16S rRNA, hsp65, sodA, recA and rpoB genes, identified the nine isolates as representatives of three novel mycobacterial species. No gene sequence variation was observed among isolates belonging to the same species.
DNA G+C content and fatty acid analysis
The DNA G+C content was 63-65 mol% and the results are summarized in Table 1 . GLC analyses of the fatty acids of isolates revealed the expected pattern diagnostic for members of the genus Mycobacterium. 
DISCUSSION
16S rRNA gene sequencing has been used as the reference method for identifying unusual mycobacterial isolates (Pauls et al., 2003; Tortoli et al., 2001; Turenne et al., 2001) . This approach has contributed to the description of 45 novel NTM species over the last 10 years. However, the investigation of large NTM collections by 16S rRNA gene sequencing has not resolved the classification of all isolates. The use of 16S rRNA gene sequencing for the identification of clinical NTM has indicated that 37 % of such isolates remain unclassified and suggests the need for complementary molecular tools for proper phylogenetic assignment and accurate NTM identification (Pauls et al., 2003) . The common assumption that bacterial isolates are members of the same species if they have fewer than 5-15 bp differences in the 16S rRNA gene sequence (Fox et al., 1992) or if they have 16S rRNA gene sequence similarity >97 % (Drancourt et al., 2000) may not be applicable to mycobacteria, whose members are much more closely related to each other (Adékambi & Drancourt, 2004; Tortoli, 2003; Turenne et al., 2001) . Furthermore, 16S rRNA gene sequence-based descriptions of novel mycobacterial taxa are still a matter of debate because ambiguous results have been found due to the presence of two copies of the 16S rRNA gene with different sequences in the same organism (Adékambi & Drancourt, 2004; Ninet et al., 1996; Reischl et al., 1998; Turenne et al., 2001 ). Molecular tools including sodA (Zolg & Philippi-Schulz, 1994) , dnaJ (Takewaki et al., 1994) , 32-kDa protein-encoding gene (Soini & Viljanen, 1997) , hsp65 (Ringuet et al., 1999) recA (Blackwood et al., 2000) , 16S-23S rRNA internal transcribed spacer (ITS) (Park et al., 2000) , DNA gyrase genes (Dauendorffer et al., 2003) and secA1 (Zelazny et al., 2005) sequence analyses have been proposed as alternative tools for the molecular identification of NTM isolates, including RGM. However, no criteria have been validated for the delineation of species using these molecular tools. The rpoB gene is a single-copy gene encoding the b-subunit of bacterial RNA polymerase and has been previously used for the molecular identification of numerous bacterial genera, including Mycobacterium (Adékambi Kim et al., 1999; Lee et al., 2003) . In this study, when rpoB gene sequencing was applied to improve the genetic identification of clinical RGM isolates, we obtained 9/59 clinical isolates (15?3 %) that exhibited >3 % rpoB gene sequence divergence from the closest related species. However, 7/9 isolates (77?8 %) shared 100 % similarity with the corresponding 16S rRNA gene sequence. Similarly, Blackwood et al. (2000) found that Mycobacterium peregrinum ATCC 14467 T and M. peregrinum ATCC 23015, which have complete 16S rRNA gene sequence identity, diverged by 3?9 % in the 915 bp recA gene sequence; the intraspecies variation of mycobacteria was <1?3 %.
Sequencing of the rpoB gene alone revealed that 15?3 % of isolates were deemed to be novel, corresponding to three novel species, whereas conventional 16S rRNA gene sequencing identified only 3?4 % of the isolates as novel, corresponding to one novel species. The intraspecies similarity of the 915 bp recA gene ranges from 98?7 to 100 % (Blackwood et al., 2000) . This additional finding allowed us to consider the sequences which were deemed to be novel as representing genuine novel species. Further molecular analysis, including hsp65 and sodA gene sequence analyses, confirmed that the nine isolates represented Mycobacterium species that were distinct from known Mycobacterium species. These data illustrate that rpoB gene sequencing is a powerful tool for the characterization of novel RGM species, as previously illustrated by the use of the rpoB gene sequence for the delineation of 'M. massiliense ' (Adékambi et al., 2004) and Mycobacterium cosmeticum .
Previous studies have shown that the antibiotic susceptibility of RGM varies widely (Brown et al., 1992; Swenson et al., 1985; Wallace et al., 1990 Wallace et al., , 1991 Woods et al., 2000) . Large variations in antibiotic susceptibility to the currently available anti-RGM antimicrobials among isolates that apparently belong to the same RGM species has confirmed the need for accurate identification at the species level (Yang et al., 2003; Yakrus et al., 2001) . Our results clearly demonstrate that species of the M. mucogenicum group were often more susceptible to antibiotics than species of the M. chelonae-abscessus group. Notable differences were found for antibiotics such as the tetracyclines (minocycline and doxycycline), the macrolides (erythromycin and azithromycin), the quinolones (ciprofloxacin, ofloxacin and sparfloxacin) and imipenem. Amikacin was effective against almost all species. Our data showed that first-and thirdgeneration cephalosporins demonstrated poor activities against members of each group whereas cefoxitin had variable activity. Although the predictive value of in vitro antibiotic susceptibility testing of RGM is uncertain, some anti-RGM antimicrobials could be useful markers for differentiating the three novel species from closely related species. Unlike M. mucogenicum ATCC 49650 T , strain U8 T was susceptible to tobramycin (MIC<4 mg ml
21
) and strain N4 T was resistant to amoxycillin (MIC >64 mg ml 21 ), amoxycillin/clavulanate (MIC>4 mg ml
) and trimethoprim/ sulfamethoxazole (MIC>8 mg ml
). Strain BD T was resistant to clarithromycin (MIC >256 mg ml 21 ) but M. abscessus was susceptible, even though they shared 100 % similarity in 16S rRNA gene sequences. Recent antibiotic susceptibility testing disturbingly showed that 21-36 % of M. abscessus isolates were resistant to clarithromycin (Yang et al., 2003; Yakrus et al., 2001) , making the differentiation of strain BD T and M. abscessus important. In another case, Mycobacterium boenickei and Mycobacterium neworleansense, which share 99?9 % similarity in 16S rRNA gene sequences, differed in their susceptibility to doxycycline and minocycline (Schinsky et al., 2004) . These data illustrate that accurate identification of emerging RGM species can reveal the presence of large variations in susceptibility to the currently available anti-RGM antimicrobials.
The polyphasic approach we adopted showed clear-cut differences between closely related species with identical 16S rRNA gene sequences. Indeed, 16S rRNA gene sequence identity alone is not a useful criterion for the identification of mycobacteria. A review of the 13 novel mycobacterial species described in the 2004 issues of International Journal of Systematic and Evolutionary Microbiology indicated that only 6/13 descriptions of novel species incorporated DNA-DNA hybridization results, including only 4/9 novel species which exhibited greater than 99 % 16S rRNA gene sequence similarity with the most closely related species. Furthermore, DNA-DNA hybridization was performed by only one of the nine research groups that proposed novel species in 2004. These data indicate that the majority of novel mycobacterial species are not described on the basis of DNA-DNA hybridization, even when 16S rRNA gene sequences are almost identical. In these cases, species were described on the basis of one to three other gene sequences. We performed sequence analysis for five different genes in the present study. These findings are in agreement with the proposition of the ad hoc committee for re-evaluation of the species definition to sequence five housekeeping genes instead of DNA-DNA hybridization in order to describe novel species (Stackebrandt et al., 2002) . Due to the highly conserved nature of the 16S rRNA gene, there is no linear correlation between the DNA-DNA relatedness value and 16S rRNA gene sequence similarity for closely related organisms (Grimont, 1988; Stackebrandt & Goebel, 1994) . For example, M. houstonense shared 100 % 16S rRNA gene sequence similarity to M. senegalense but in DNA-DNA hybridization studies, labelled genomic DNA from M. houstonense was <65 % related to that of M. senegalense (Schinsky et al., 2004) . Using the rpoB gene as an alternative tool, M. houstonense shared 97?0 % sequence similarity to M. senegalense (Adékambi et al., 2003) . This similarity value fulfils the definition of a novel mycobacterial species (Adékambi et al., 2003) . Without DNA-DNA hybridization, the rpoB gene has been used for the description of novel mycobacterial species such as 'M. massiliense ' and M. cosmeticum (Adékambi et al., 2004, Cooksey et al., 2004) . Furthermore, recent studies with species of Bartonella, Bosea and Afipia have shown a correlation between DNA-DNA relatedness and rpoB gene sequence similarity for closely related organisms and rpoB gene sequencing has been proposed for the classification of isolates misidentified by 16S rRNA gene sequencing La Scola et al., 2003) .
A species diagnosis is essential for the management of patients with RGM infections. For example, it is well known that infections with M. abscessus in patients with cystic fibrosis or with chronic meningitis are very difficult to treat (Sanguinetti et al., 2001; Maniu et al., 2001) . In some cases, M. abscessus is essentially ineradicable with the possible exception of a resection of the affected lobe of the lung (Griffith et al., 1993; Wallace et al., 1997) . Knowledge of the characteristics of mycobacterial species is important for the treatment and prognosis of patients with RGM. Thus, all clinical isolates of RGM should be identified to the species level. Phenotypic characterization, including pigmentation, growth rate, biochemical test algorithms and 16S rRNA gene sequencing, have been used in the identification of Mycobacterium species since the earliest isolation of RGM in clinical specimens. However, rpoB gene sequencing has revealed advantages over both conventional testing and 16S rRNA gene sequence analysis for identifying mycobacterial species and detecting novel species. In keeping with previous findings, it can generally be assumed that a novel species has been detected if base pair discrepancies are found in the variable regions of the rpoB gene and the organism has distinct phenotypic properties (Adékambi et al., 2004) .
Molecular identification of mycobacteria is a key step towards the description of emerging RGM species and the opportunistic infections they cause. The characteristics of one of the novel species described in this paper, Mycobacterium bolletii sp. nov., also illustrate that accurate identification of RGM can be predictive of antibiotic susceptibility patterns of prime clinical value. The present data indicate that selected partial rpoB gene sequencing could be used as a first-line molecular tool for the accurate identification of emerging RGM in man.
Description of Mycobacterium bolletii sp. nov.
Mycobacterium bolletii (bol9let.i.i. N.L. gen. n. bolletii of Bollet, to honour our deceased colleague Claude Bollet, a famous clinical microbiologist and taxonomist).
The organisms are acid-fast and Gram-positive bacilli. Colonies are non-pigmented and appear on 5 % sheep blood agar, Middlebrook 7H10 agar and egg-based LJ slants in 2-5 days at temperatures between 24 and 37 uC, optimally at 30 uC. No growth occurs at 42 uC. This species is a multidrug-resistant mycobacteria, notably to clarithromycin but with intermediate resistance to amikacin. It is associated with chronic pneumonia. It is positive for 3-day arylsulfatase activity, negative for iron uptake and urease activity, does not grow on LJ containing 5 % NaCl at 35 u C and does not utilize citrate, sorbitol or mannitol as sole sources of carbon. It shares 100 % 16S rRNA and 95?6 % rpoB gene sequence similarity with M. abscessus, the closest species.
The type strain, BD T (=CIP 108541 T =CCUG 50184 T ), was recovered from sputum.
Description of Mycobacterium phocaicum sp. nov.
Mycobacterium phocaicum [pho.cai9cum. L. neut. adj. phocaicum pertaining to Phocaea, a maritime town of lonia, a colony of the Athenians, whose inhabitants fled to escape from Persian domination and founded Massilia (Marseille), which was the source of the type strain].
The organisms are acid-fast and Gram-positive bacilli. Colonies are non-pigmented and appear on 5 % sheep blood agar, Middlebrook 7H10 agar and egg-based LJ slants in 2-5 days at temperatures between 24 and 37 u C, optimally at 30 uC. No growth occurs at 42 uC. This species is associated with chronic pneumonia. It is susceptible in vitro to cefoxitin, imipenem, minocycline, doxycycline, clarithromycin, erythromycin, azithromycin, amikacin, ciprofloxacin, ofloxacin and sparfloxacin and is resistant to amoxycillin, amoxycillin/clavulanate and tobramycin. It is positive for 3-day arylsulfatase, nitrate reductase and pyrazinamidase activities and for the production of aesculin and acetoin and negative for iron uptake and urease activity. M. phocaicum differs from M. mucogenicum ATCC 49650 T by exhibiting positive activity for penicillinase and alkaline phosphatase and by utilizing citrate as a sole source of carbon. It shares 100 % 16S rRNA and 95?0 % rpoB gene sequence similarity with M. mucogenicum ATCC 49650 T , the closest phylogenetic species.
The type strain, N4
T (=CIP 108542 T =CCUG 50185 T ), was recovered from bronchial aspirate.
Description of Mycobacterium aubagnense sp. nov.
Mycobacterium aubagnense (au.bag.nen9se. N.L. neut. adj. aubagnense pertaining to Aubagne, the city from where the first patient originated).
The organisms are acid-fast and Gram-positive bacilli. Colonies are non-pigmented and appear on 5 % sheep blood agar, Middlebrook 7H10 agar and egg-based LJ slants in 2-5 days at temperatures between 24 and 37 uC, optimally at 30 uC. No growth occurs at 42 uC. This species is associated with chronic pneumonia and sepsis. It is susceptible in vitro to amoxycillin, amoxycillin/clavulanate, cefoxitin, imipenem, minocycline, doxycycline, clarithromycin, erythromycin, azithromycin, amikacin, tobramycin, ciprofloxacin, ofloxacin, sparfloxacin and trimethoprim/sulfamethoxazole. It is positive for 3-day arylsulfatase activity and for the production of aesculin and acetoin, but negative for iron uptake and urease activity. Does not utilize citrate as a sole source of carbon. M. aubagnense differs from M. mucogenicum ATCC 49650
T by exhibiting positive alkaline phosphatase activity and no nitrate reductase or pyrazinamidase activity. It shares 99?1 % 16S rRNA and 92?7 % rpoB gene sequence similarity with M. mucogenicum ATCC 49650 T , the closest phylogenetic species.
The type strain, U8
T (=CIP 108543 T =CCUG 50186 T ), was recovered from bronchial aspirate.
